Banmeet Anand
Corporate Officer/Principal chez HARPOON THERAPEUTICS, INC.
Provenance du réseau au premier degré de Banmeet Anand
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Banmeet Anand via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Director/Board Member | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Chairman | |
| AEROCRINE AB | Electronic Equipment/Instruments | Chief Executive Officer | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
Ironshore Therapeutics, Inc.
 Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chairman | |
| ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Director of Finance/CFO Comptroller/Controller/Auditor | |
| ARTELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Chief Executive Officer | |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia. | Investment Banks/Brokers | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
| Swarthmore College | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Undergraduate Degree | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| SENSORION | Pharmaceuticals: Major | Chairman | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Beal Advisors LLC
 Beal Advisors LLC Investment ManagersFinance Beal Advisors LLC provides investment advice services. The private company is based in Walnut Creek, CA. The company was founded by Georgia L. Erbez. | Investment Managers | Founder | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director of Finance/CFO | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman |
Statistiques
Internationale
| Etats-Unis | 40 |
| Suède | 3 |
| Canada | 3 |
| Irlande | 3 |
| Belgique | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 3 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 94 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 39 |
| Director of Finance/CFO | 20 |
| Undergraduate Degree | 18 |
Relations les plus connectées
| Insiders | |
|---|---|
| Alan Colowick | 30 |
| Ron Hunt | 29 |
| Mark Chin | 25 |
| Scott Myers | 18 |
| Joanne Viney | 18 |
| Georgia Erbez | 18 |
| Julia Eastland | 16 |
| Lauren Silvernail | 14 |
| Joseph Bailes | 12 |
| Andrew Robbins | 11 |
| Jonathan Drachman | 10 |
| James B. Bucher | 7 |
| Frank Lanza | 6 |
| Karin Ann Thacker | 5 |
| Haibo Wang | 5 |
- Bourse
- Insiders
- Banmeet Anand
- Connexions Sociétés
